Saratoga Investment Corp. Announces Fiscal Second Quarter 2027 Financial Results

Saratoga Investment’s fiscal Q2 2027 AUM rose 2.1% sequentially to $1.150 billion, with $37.1 million of net originations and adjusted NII of $0.46 per share versus $0.47 in the prior quarter. NAV fell 6.8% to $352.6 million, or $22.15 per share, amid $14.4 million of portfolio markdowns; quarterly EPS was a loss of $0.41 and last-12-month ROE was negative 1.1%. Non-accrual investments were 0.0% of portfolio fair value and 1.3% of cost, and Saratoga repurchased 444,124 shares for approximately $8.4 million, adding about $0.09 per share to NAV. The company maintained its $0.75-per-share quarterly dividend and refinanced debt, while management cited competitive, volatile private-credit conditions and company-specific valuation pressure.

Analysis

SAR — High yield masks a shrinking earnings cushion

The key equity risk is distribution coverage, not the headline non-accrual ratio: adjusted NII of $0.46 per share covers only about 61% of the $0.75 quarterly dividend. Persistent reliance on undistributed earnings or capital to sustain the payout would compound NAV erosion; a cut could also remove a major support for the stock. The discount to NAV and below-NAV repurchases offer some cushion, but buybacks cannot offset recurring credit marks and excess distributions.

Near term, the October 7 call is the catalyst: focus on management’s dividend rationale, realized recovery on exited credits, and whether marks in Madison Logic, Exigo and Chronus are stabilizing. Exiting the named non-accruals reduces reported non-accrual exposure, but is not evidence that portfolio stress has ended. Over 1–3 months, the more consequential signal is whether new deployment can replace repayments without further spread compression. Originations replacing repayments at 220bp lower spreads create a structural earnings headwind; higher base rates help only if asset repricing exceeds borrower stress and incremental funding costs. Over 6–18 months, further markdowns would pressure NAV, leverage capacity and buyback flexibility.

Contrarian point: the 18.1% indicated yield and discount to NAV may already price substantial distress, while the CLO reset and refinancing reduce some funding uncertainty. But the company’s claim of improving market differentiation is not yet validated by per-share earnings or asset marks. VLY and LOB are identified only as facility providers; the release does not quantify a material earnings effect for either. No reliable valuation or bond-spread data are provided to support a target or a debt recommendation.

Key Decisions for Investors

• Avoid adding to SAR common ahead of the call; existing holders should treat the dividend as at risk until management demonstrates a credible path toward recurring NII coverage.
• Use the October 7 call to test for stabilization: track additional markdowns or non-accruals, realized recovery versus carrying value on exits, and adjusted NII per share relative to the dividend.
• Watch SAR’s relative performance versus BDC peers rather than forcing a short: consider a cautious underweight only if the discount narrows without improving coverage, or if further credit marks emerge. Falsifiers include sustained NII coverage improvement and stable portfolio marks.
• Do not infer a trade in VLY or LOB from this release; the facility relationships are mentioned without quantified material impact.